Agilent Technologies (FRA:AG8) LT-Debt-to-Total-Asset : 0.23 (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Agilent Technologies's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 0.23.

Agilent Technologies's long-term debt to total assets ratio declined from Jan. 2023 (0.25) to Jan. 2024 (0.23). It may suggest that Agilent Technologies is progressively becoming less dependent on debt to grow their business.

Agilent Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Agilent Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies LT-Debt-to-Total-Asset Chart

Agilent Technologies Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.19

0.24

0.26

0.25

Agilent Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.25	0.25	0.26	0.25	0.23

Agilent Technologies LT-Debt-to-Total-Asset Calculation

Agilent Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as

LT Debt to Total Assets (A: Oct. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Oct. 2023 )	/	Total Assets (A: Oct. 2023 )
	=	2590.045	/	10192.561
	=	0.25

Agilent Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )	/	Total Assets (Q: Jan. 2024 )
	=	2345.49	/	10050.264
	=	0.23

Agilent Technologies (FRA:AG8) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Agilent Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies (FRA:AG8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (FRA:AG8) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

A:USA A:Mexico 1A:Italy AG8:Germany

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Agilent Technologies (FRA:AG8) Headlines

No Headlines